Moneycontrol
HomeNewsBusinessEconomyExclusive | Woes for manufacturing sector to continue, irrespective of jump in Q1FY22, say experts
Trending Topics

Exclusive | Woes for manufacturing sector to continue, irrespective of jump in Q1FY22, say experts

Though the sector clocked a 6.9 percent growth in Q4FY21 in the IHS Markit India index, it was calculated on the low base of the previous year, they say. With domestic demand suffering a setback across the country, the challenges to manufacturing continue and are expected to exacerbate in the coming quarter.

June 01, 2021 / 16:40 IST
Story continues below Advertisement
Representational image ( Shutterstock)

While Q1FY22 is expected to see a large manufacturing growth, experts say it will not paint a realistic picture of the sector. The on-paper jump will be due to a low base effect and the fact that systemic pressures in the sector have continued in the fourth quarter of FY22.

Contrary to the positive speculation regarding the health of the manufacturing sector, which clocked a 6.9 percent growth in Q4FY21 (January-March 2021), experts warn that the sector is in for tough times in the upcoming quarters.

Story continues below Advertisement

Experts point out that growth is already calculated on a low base. Even a year back, in the January-March period of 2020, before COVID-19 set in and lockdowns began, the manufacturing sector was reeling. It had contracted by 4.2 percent then.

"This shows internal pressures in the sector have continued. Also, with domestic demand seeing a setback across the country, the challenges to manufacturing continue and are expected to exacerbate in the coming quarter," India Ratings chief economist Devendra Pant said.

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show